HC Wainwright & Co. Reiterates Buy on 89bio, Maintains $35 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Ed Arce has reiterated a Buy rating on 89bio (NASDAQ:ETNB) and maintained a $35 price target for the company's stock.
December 05, 2023 | 11:21 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Ed Arce has reiterated a Buy rating on 89bio and maintained a $35 price target, potentially influencing investor confidence and the stock's performance.
The reiteration of a Buy rating and the maintenance of a $35 price target by a reputable analyst could lead to increased investor confidence in 89bio, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100